WithdrawnNCT02955654
Acceptance and Commitment Therapy in SSRI-Resistant OCD
Researchers are comparing acceptance and commitment therapy and Aripiprazole to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.
Medication studyAges 18–65
Understand this study
What is this study about?
Researchers are comparing acceptance and commitment therapy and Aripiprazole to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.
Who could participate?
Listed age limits: 18 years to 65 years.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 1, 2017
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02955654
- Official title
Show the full official title
Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder
Recruitment & locations
WithdrawnLocations not listed
Questions about this study
What is this study about?
Researchers are comparing acceptance and commitment therapy and Aripiprazole to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Aripiprazole.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
